Intubating conditions after pipecuronium bromide: the influence of dose and time.
暂无分享,去创建一个
J. Seltzer | M. Goldberg | R. Bartkowski | G. Larijani | S. Azad | A. Marr | M. Weinberger
[1] P. Glass,et al. Onset and duration of neuromuscular blockade following high-dose vecuronium administration. , 1989, Anesthesiology.
[2] J. Seltzer,et al. A Dose‐Response Evaluation of Pipecuronium Bromide in Elderly Patients Under Balanced Anesthesia , 1989, Journal of clinical pharmacology.
[3] J. Seltzer,et al. Clinical Pharmacology of Pipecuronium Bromide , 1989, Anesthesia and analgesia.
[4] F. Donati,et al. Neostigmine, pyridostigmine and edrophonium as antagonists of deep pancuronium blockade , 1987 .
[5] H. Nagashima,et al. THE HUMAN CUMULATIVE DOSE-RESPONSE OF PIPECURONIUM BROMIDE UNDER BALANCED ANESTHESIA , 1986 .
[6] H. H. Ali,et al. CLINICAL PHARMACOLOGY OF ATRACURIUM GIVEN IN HIGH DOSE , 1986 .
[7] R. Katz. Muscle relaxants : basic and clinical aspects , 1985 .
[8] Chingmuh Lee. Succinylcholine: Its past, present, and future , 1984 .
[9] D. R. Cook. Muscle Relaxants in Infants and Children , 1981, Anesthesia and analgesia.
[10] I. Tóth,et al. Comparative clinical study of pipecurium bromide and pancuronium bromide. , 1980, Arzneimittel-Forschung.